Kazutaka Takagi

Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance

Smitha Antony, Keli Agama, Ze‐Hong Miao et al. · Cancer Research · 2007 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Yasufumi Masaki, Shoko Matsui, Takako Saeki et al. · Modern Rheumatology · 2016 · 92 citations

Life Sciences, Immunology, Pharmacotherapy +16

Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters

Kazutaka Takagi, Thomas S. Dexheimer, Christophe E. Redon et al. · Molecular Cancer Therapeutics · 2007 · 52 citations

Medicine, Oncology, Pharmacology +12

Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells

Takahiro Yamauchi, Eiju Negoro, Shinji Kishi et al. · Biochemical Pharmacology · 2009 · 50 citations

Life Sciences, Molecular Biology, Oncology +13

Von Hippel-Lindau–Coupled and Transcription-Coupled Nucleotide Excision Repair–Dependent Degradation of RNA Polymerase II in Response to Trabectedin

Gregory J. Aune, Kazutaka Takagi, Olivier Sordet et al. · Clinical Cancer Research · 2008 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +13